Unknown

Dataset Information

0

SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways.


ABSTRACT: SMYD3 is a member of the SMYD lysine methylase family and plays an important role in the methylation of various histone and non-histone targets. Aberrant SMYD3 expression contributes to carcinogenesis and SMYD3 upregulation was proposed as a prognostic marker in various solid cancers. Here we summarize SMYD3-mediated regulatory mechanisms, which are implicated in the pathophysiology of cancer, as drivers of distinct oncogenic pathways. We describe SMYD3-dependent mechanisms affecting cancer progression, highlighting SMYD3 interplay with proteins and RNAs involved in the regulation of cancer cell proliferation, migration and invasion. We also address the effectiveness and mechanisms of action for the currently available SMYD3 inhibitors. The findings analyzed herein demonstrate that a complex network of SMYD3-mediated cytoplasmic and nuclear interactions promote oncogenesis across different cancer types. These evidences depict SMYD3 as a modulator of the transcriptional response and of key signaling pathways, orchestrating multiple oncogenic inputs and ultimately, promoting transcriptional reprogramming and tumor transformation. Further insights into the oncogenic role of SMYD3 and its targeting of different synergistic oncogenic signals may be beneficial for effective cancer treatment.

PROVIDER: S-EPMC7017119 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC4537039 | BioStudies
2015-01-01 | S-EPMC4605318 | BioStudies
2015-01-01 | S-EPMC4988495 | BioStudies
2019-01-01 | S-EPMC6872730 | BioStudies
2014-01-01 | S-EPMC4122675 | BioStudies
2018-01-01 | S-EPMC6379668 | BioStudies
2011-01-01 | S-EPMC3136521 | BioStudies
2017-01-01 | S-EPMC5529954 | BioStudies
2020-01-01 | S-EPMC7041758 | BioStudies
2011-01-01 | S-EPMC3105404 | BioStudies